Bioconversion of stilbenes in genetically engineered root and cell cultures of tobacco

Hidalgo, Diego; Martínez-Márquez, Ascensión; Moyano Claramunt, Elisabet; Bru-Martínez, Roque; Corchete, Purificación; Palazón Barandela, Javier

doi:http://dx.doi.org/10.1038/srep45331

Bioconversion of stilbenes in genetically engineered root and cell cultures of tobacco

License

Citation

Hidalgo D, Martínez-Márquez A, Moyano Claramunt E, Bru-Martínez R, Corchete P, Palazon J. Bioconversion of stilbenes in genetically engineered root and cell cultures of tobacco. Scientific Reports. 2017; 7: 45331. DOI: 10.1038/srep45331

Abstract

It is currently possible to transfer a biosynthetic pathway from a plant to another organism. This system has been exploited to transfer the metabolic richness of certain plant species to other plants or even to more simple metabolic organisms such as yeast or bacteria for the production of high added value plant compounds. Another application is to bioconvert substrates into scarcer or biologically more interesting compounds, such as piceatannol and pterostilbene. These two resveratrol-derived stilbenes, which have very promising pharmacological activities, are found in plants only in small amounts. By transferring the human cytochrome P450 hydroxylase 1B1 (HsCYP1B1) gene to tobacco hairy roots and cell cultures, we developed a system able to bioconvert exogenous t-resveratrol into piceatannol in quantities near to mg L−1. Similarly, after heterologous expression of resveratrol O-methyltransferase from Vitis vinifera (VvROMT) in tobacco hairy roots, the exogenous t-resveratrol was bioconverted into pterostilbene. We also observed that both bioconversions can take place in tobacco wild type hairy roots (pRiA4, without any transgene), showing that unspecific tobacco P450 hydroxylases and methyltransferases can perform the bioconversion of t-resveratrol to give the target compounds, albeit at a lower rate than transgenic roots.